Eyenovia
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 57
- Market Cap
- $43.8M
- Website
- http://www.eyenovia.com
- Introduction
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage dev...
Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06217796
- Locations
- πΊπΈ
SUNY, New York, New York, United States
Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT05114486
- Locations
- πΊπΈ
VISION-2 Study Site #61, Draper, Utah, United States
πΊπΈVISION-2 Study Site #56, Louisville, Kentucky, United States
πΊπΈVISION-2 Study Site #19, Columbus, Ohio, United States
Evaluation of Pupil Dilation Speed With the MAP Dispenser
- Conditions
- Interventions
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04907474
- Locations
- π²π½
CODET Vision Institute, Tijuana, Baja California, Mexico
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
- First Posted Date
- 2020-12-08
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT04657172
- Locations
- πΊπΈ
VISION-1 Study Site #54, Fort Collins, Colorado, United States
πΊπΈVISION-1 Study Site #21, Azusa, California, United States
πΊπΈVISION-1 Study Site #53, Orlando, Florida, United States
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
- Conditions
- Interventions
- First Posted Date
- 2019-05-08
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT03942419
- Locations
- πΊπΈ
University of Alabama at Birmingham School of Optometry, Birmingham, Alabama, United States
πΊπΈMidwestern University, Downers Grove, Illinois, United States
πΊπΈCanyon City Eyecare, Azusa, California, United States
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT03751631
- Locations
- πΊπΈ
WCCT, Cypress, California, United States
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
- Conditions
- Interventions
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT03751098
- Locations
- πΊπΈ
Keystone Research, Austin, Texas, United States
πΊπΈR&R Research, San Antonio, Texas, United States
Eyenovia MiDD Usability Study
- First Posted Date
- 2018-03-29
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03480906
- Locations
- π΅π¦
Clinica de Ojos Orillac-Calvo, Panama City, Panama
Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil
- Conditions
- Interventions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Eyenovia Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02946125